ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

AUTL Autolus Therapeutics PLC

4,19
0,08 (1,95%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Autolus Therapeutics PLC AUTL NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,08 1,95% 4,19 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,22 4,055 4,37 4,19 4,11
mais cotações »

Notícias Recentes

Data Hora Fonte Título
24/04/202411:00GLOBEAbstract for longer-term follow-up and additional data..
23/04/202408:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/04/202408:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/04/202408:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/03/202408:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/03/202408:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/03/202408:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/02/202409:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
22/02/202409:00GLOBEAutolus Therapeutics announces publication in Nature..
08/02/202409:00GLOBEAutolus Announces Pricing of Underwritten Offering
08/02/202407:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
23/01/202409:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22/01/202409:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22/01/202409:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
10/01/202409:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
22/12/202309:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
09/12/202322:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
28/11/202316:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202309:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27/11/202309:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15/11/202309:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
06/11/202309:00GLOBEAutolus Therapeutics announces participation in upcoming..
02/11/202310:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
02/11/202308:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
17/10/202308:00GLOBEAutolus Therapeutics to host virtual event to discuss the..
11/10/202309:07GLOBECorrection - Autolus Therapeutics to report third quarter..
11/10/202308:00GLOBEAutolus Therapeutics to report third quarter 2023 financial..
05/09/202308:00GLOBEAutolus Therapeutics announces data from AUTO1/22 trial in..
03/08/202308:00GLOBEAutolus Therapeutics Reports Second Quarter 2023 Financial..
18/07/202308:00GLOBEAutolus Therapeutics to report second quarter 2023 financial..
06/07/202308:00GLOBEAutolus Therapeutics announces a publication in Nature..
27/06/202308:00GLOBEAutolus Therapeutics announces publication in Cancer..
20/06/202308:00GLOBEAutolus Therapeutics strengthens its Board with the..
16/06/202308:00GLOBEAutolus Therapeutics Presents Positive Results from AUTO4 in..
06/06/202308:00GLOBEAutolus to hold Annual General Meeting (AGM) of Shareholders..
02/06/202308:00GLOBEAutolus Therapeutics Presents Positive Results from Pivotal..
22/05/202308:00GLOBEAutolus Therapeutics to hold Analyst call to highlight data..
12/05/202308:00GLOBEAutolus Therapeutics announces Pivotal Phase 2 FELIX study..

Seu Histórico Recente

Delayed Upgrade Clock